Royce & Associates LP Biolife Solutions Inc Transaction History

Royce & Associates LP

$9.25 Billion
Q2 2025

A detailed history of Royce & Associates LP transactions in Biolife Solutions Inc stock. As of the latest transaction made, Royce & Associates LP holds 521,805 shares of BLFS stock, worth $13.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

521,805

Previous 860,744 39.38%

Holding current value

$13.3 Million

Previous $19.7 Million 42.83%

% of portfolio

0.12%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$20.64 - $25.27 $7 Million - $8.56 Million	-338,939 Reduced 39.38%	521,805 $11.2 Million
Q1 2025 May 06, 2025	BUY	$22.84 - $28.49 $1.91 Million - $2.38 Million	83,462 Added 10.74%	860,744 $19.7 Million
Q4 2024 Feb 10, 2025	SELL	$20.47 - $27.47 $979,509 - $1.31 Million	-47,851 Reduced 5.8%	777,282 $20.2 Million
Q3 2024 Nov 06, 2024	SELL	$19.19 - $26.52 $1.68 Million - $2.32 Million	-87,519 Reduced 9.59%	825,133 $20.7 Million
Q2 2024 Aug 13, 2024	BUY	$15.14 - $22.99 $6.02 Million - $9.14 Million	397,445 Added 77.14%	912,652 $19.6 Million
Q1 2024 May 13, 2024	SELL	$15.35 - $18.82 $5.47 Million - $6.71 Million	-356,396 Reduced 40.89%	515,207 $9.56 Million
Q4 2023 Feb 12, 2024	BUY	$8.99 - $16.86 $5.65 Million - $10.6 Million	628,827 Added 259.02%	871,603 $14.2 Million
Q3 2023 Nov 09, 2023	BUY	$10.81 - $22.96 $2.62 Million - $5.57 Million	242,776 New	242,776 $3.35 Million
Q3 2022 Nov 03, 2022	SELL	$14.64 - $26.7 $2,928 - $5,340	-200 Reduced 0.92%	21,600 $491,000
Q2 2022 Aug 04, 2022	BUY	$10.54 - $24.2 $229,771 - $527,560	21,800 New	21,800 $301,000
Q1 2022 May 05, 2022	SELL	$20.81 - $37.29 $1.19 Million - $2.14 Million	-57,300 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$32.99 - $58.55 $4.28 Million - $7.6 Million	-129,856 Reduced 69.38%	57,300 $2.14 Million
Q3 2021 Nov 10, 2021	BUY	$42.03 - $60.5 $82,378 - $118,580	1,960 Added 1.06%	187,156 $7.92 Million
Q2 2021 Aug 06, 2021	SELL	$29.51 - $44.62 $3.43 Million - $5.19 Million	-116,300 Reduced 38.57%	185,196 $8.24 Million
Q1 2021 May 10, 2021	SELL	$32.95 - $44.24 $17.9 Million - $24 Million	-543,620 Reduced 64.32%	301,496 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$16.04 - $28.94 $2.65 Million - $4.79 Million	165,500 Added 24.35%	845,116 $24.5 Million
Q2 2020 Aug 07, 2020	BUY	$9.2 - $17.06 $1.83 Million - $3.39 Million	198,900 Added 41.38%	679,616 $11.1 Million
Q1 2020 May 12, 2020	BUY	$8.36 - $17.03 $2.17 Million - $4.43 Million	260,000 Added 117.8%	480,716 $4.57 Million
Q4 2019 Feb 06, 2020	BUY	$14.59 - $18.9 $351,049 - $454,752	24,061 Added 12.24%	220,716 $3.57 Million
Q3 2019 Nov 13, 2019	BUY	$15.7 - $20.98 $157,000 - $209,800	10,000 Added 5.36%	196,655 $3.27 Million
Q2 2019 Aug 12, 2019	BUY	$15.2 - $19.42 $2.84 Million - $3.62 Million	186,655 New	186,655 $3.16 Million

Others Institutions Holding BLFS

# of Institutions

205

Shares Held

50.4M

Call Options Held

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.09B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Biolife Solutions Inc Transaction History